Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.49 |
| ▸ | CXCL8 | P10145 | 3/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.49 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.49 |
| ▸ | UGT1A9 | O60656 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.49 |
| ▸ | ALB | P02768 | 1/20 | 0.49 |
| ▸ | UGT1A6 | P19224 | 1/20 | 0.49 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.49 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17789154 | 0.89 | TTR (0.52) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17789163 | 0.87 | TTR (0.50) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17789162 | 0.83 | TTR (0.57) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17789167 | 0.83 | TTR (0.48) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17789178 | 0.83 | TTR (0.52) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL22859878 | 0.83 | TTR (0.48) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17789174 | 0.83 | TTR (0.46) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL21401015 | 0.83 | TTR (0.49) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17001513 | 0.81 | TTR (0.59) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL23177806 | 0.79 | TTR (0.47) | TTRCYP2C9USP2LMNATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3023108-B1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU KOGYO CO LTD (JP) | 2021-04-07 | — | — | EP | disclosed |
| US-10675354-B2 | Glycosaminoglycan derivative and method for producing same | SEIKAGAKU CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20200155694-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2020-05-21 | — | — | US | disclosed |
| US-20190184023-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200155694-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | CSGALNACT1, CD44, GUSB | TTR 2650/4885CYP2C9 1455/4885USP2 1046/4885 |
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | CSGALNACT1, CD44, GUSB | TTR 2650/4885CYP2C9 1455/4885USP2 1046/4885 |
| US-10675354-B2 | Glycosaminoglycan derivative and method for producing same | CSGALNACT1, CD44, GUSB | TTR 2650/4885CYP2C9 1455/4885USP2 1046/4885 |
| US-20190184023-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | CSGALNACT1, CD44, GUSB | TTR 2650/4885CYP2C9 1455/4885USP2 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.